Alera Investment Advisors’s DexCom DXCM Stock Holding History

Alera Investment Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-48	Closed	-$1K	–	334
2019 Q1	$1K	Hold	48	–	–	﹤0.01%	938
2018 Q4	$1K	Buy	+48	New	+$1.52K	﹤0.01%	888

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Alera Investment Advisors's DXCM Position: Q2 2019 in Review

Alera Investment Advisors sold out of DexCom (DXCM) in Q2 2019, closing a stake of 48 shares — an estimated $1K sold.

Alera Investment Advisors first reported a position in DXCM in Q4 2018 and held it in 2 quarters. The position peaked at $1K in Q1 2019. 418 funds tracked by Wall St. Rank hold DXCM as of Q2 2019.

Alera Investment Advisors reported no remaining DexCom position as of Q2 2019 after selling out during the quarter.
Alera Investment Advisors sold 48 DexCom shares in Q2 2019, an estimated $1K.
Alera Investment Advisors first reported a position in DexCom in Q4 2018 and held it in 2 quarters.
Alera Investment Advisors's DexCom position peaked at $1K in Q1 2019.
418 funds tracked by Wall St. Rank held DexCom as of Q2 2019.

Based on Alera Investment Advisors's 13F filing for Q2 2019, filed 7 Aug 2019.